(Q30413350)

14 August 2017

A randomized controlled trial of pretransplant antiviral therapy to prevent recurrence of hepatitis C after liver transplantation (English)

1 reference

14 August 2017

liver transplantation

1 reference

1 reference

2

Norah A Terrault

1 reference

14 August 2017

6

Sammy Saab

1 reference

14 August 2017

Gregory T Everson

1

1 reference

14 August 2017

Anna S Lok

3

1 reference

14 August 2017

Del R Rodrigo

4

1 reference

14 August 2017

Robert S Brown

5

1 reference

14 August 2017

Mitchell L Shiffman

7

1 reference

14 August 2017

Abdullah M S Al-Osaimi

8

1 reference

14 August 2017

Laura M Kulik

9

1 reference

14 August 2017

Brenda W Gillespie

10

1 reference

14 August 2017

James E Everhart

11

1 reference

14 August 2017

Adult-to-Adult Living Donor Liver Transplantation Cohort Study

12

1 reference

14 August 2017

language of work or name

English

0 references

publication date

17 January 2013

1 reference

14 August 2017

1 reference

14 August 2017

57

1 reference

14 August 2017

5

1 reference

14 August 2017

1752-1762

1 reference

Estimating population distributions when some data are below a limit of detection by using a reverse Kaplan-Meier estimator

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3510348

Diagnosis, management, and treatment of hepatitis C: an update

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3510348

Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3510348

What determines the natural history of recurrent hepatitis C after liver transplantation?

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3510348

Natural history and management of hepatitis C infection after liver transplantation

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3510348

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3510348

Report of the first International Liver Transplantation Society expert panel consensus conference on liver transplantation and hepatitis C.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3510348

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3510348

A pilot study of the tolerability and efficacy of antiviral therapy in hepatitis C virus-infected patients awaiting liver transplantation

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3510348

The association between hepatitis C infection and survival after orthotopic liver transplantation

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3510348

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3510348

Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment

20 June 2018

1 reference

Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: Lessons from the HALT-C trial.

21 January 2018

1 reference

Peginterferon alfa-2b and ribavirin: effective in patients with hepatitis C who failed interferon alfa/ribavirin therapy

21 January 2018

1 reference

Antiviral therapy of patients with decompensated cirrhosis to prevent recurrence of hepatitis C after liver transplantation.

21 January 2018

1 reference

Infection with chronic hepatitis C virus and liver transplantation: a role for interferon therapy before transplantation.

21 January 2018

1 reference

Antiviral therapy increases the risk of bacterial infections in HCV-infected cirrhotic patients awaiting liver transplantation: A retrospective study.

21 January 2018

1 reference

Impact of reducing peginterferon alfa-2a and ribavirin dose during retreatment in patients with chronic hepatitis C.

21 January 2018

1 reference

Hepatitis C virus treatment-related anemia is associated with higher sustained virologic response rate

21 January 2018

1 reference

Liver Transplantation and Hepatitis C. Proceedings of a consensus development symposium

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/HEP.25976

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

22821361

1 reference